Cost-effectiveness of a melanoma screening programme using whole disease modelling:

Alessandra Buja,Michele Rivera,Giovanni Girardi,A. Vecchiato,Vincenzo Rebba,Elena Pizzo,Vanna Chiarion Sileni,Angelo Claudio Palozzo,Maria Cristina Montesco,Manuel Zorzi,Gino Sartor,Manuela Scioni,Mario Bolzan,Paolo Del Fiore,Maria Giuseppina Bonavina,Massimo Rugge,Vincenzo Baldo,Carlo Riccardo Rossi

Cost-effectiveness of a melanoma screening programme using whole disease modelling:

2019

Alessandra Buja
Michele Rivera
Giovanni Girardi
A. Vecchiato
Vincenzo Rebba
Elena Pizzo
Vanna Chiarion Sileni
Angelo Claudio Palozzo
Maria Cristina Montesco
Manuel Zorzi
Gino Sartor
Manuela Scioni
Mario Bolzan
Paolo Del Fiore
Maria Giuseppina Bonavina
Massimo Rugge
Vincenzo Baldo
Carlo Riccardo Rossi

ObjectiveTo assess the potential impact of a melanoma screening programme, compared with usual care, on direct costs and life expectancy in the era of targeted drugs and cancer immunotherapy.Method...

Keywords:

Physical therapy
Cancer immunotherapy
Indirect costs
Medicine
Melanoma
Intensive care medicine
Life expectancy
Disease
Time horizon
Population
Family medicine
cost effectiveness
screening programme

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations